Seminars in Roentgenology
Volume 43, Issue 4 , Pages 303-313 , October 2008

Multiparametric Magnetic Resonance Imaging of the Prostate: Current Status in Prostate Cancer Detection, Localization, and Staging

  • Katarzyna J. Macura, MD, PhD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Katarzyna J. Macura, MD, PhD, The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N. Caroline Street, JHOC 3140C, Baltimore, MD 21287-0750

References 

  1. American Cancer Society. Cancer facts and figures 2007 (Publication no. 500807). Atlanta, GA: American Cancer Society; 2006;
  2. Okotie OT, Roehl KA, Han M, et al. Characteristics of prostate cancer detected by digital rectal examination only. Urology. 2007;70(6):1117–1120
  3. Smith DS, Catalona WJ. Interexaminer variability of digital rectal examination in detecting prostate cancer. Urology. 1995;45:70–74
  4. Karakiewicz PI, Benayoun S, Kattan WM, et al. Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen. J Urol. 2005;173:1930–1934
  5. Bozeman CB, Carver BS, Caldito G, et al. Prostate cancer in patients with an abnormal digital rectal examination and serum prostate-specific antigen less than 4.0 ng/mL. Urology. 2005;66:803–807
  6. Bosch JL, Bohnen AM, Groeneveld FP. Validity of digital rectal examination and serum prostate specific antigen in the estimation of prostate volume in community-based men aged 50 to 78 years: the Krimpen Study. Eur Urol. 2004;46:753–759
  7. Catalona WJ, Smith DS, Ratliff TL, et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med. 1991;324:1156–1161
  8. Thompson IM, Pauler DK, Goodman PJ, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter. N Engl J Med. 2004;350(22):2239–2246
  9. Mettlin C. Preliminary findings from the American Cancer Society National Prostate Cancer Detection Project. In: Proceedings of the 5th International Symposium on Transrectal Ultrasound in the Diagnosis and Management of Prostate Cancer, September 14. Chicago, IL. 1990;p. 84–85
  10. Levine MA, Ittman M, Melamed J, et al. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol. 1998;159:471–476
  11. Steven D, McCabe K, Peretsman S, et al. Prostate rebiopsy is a poor surrogate of treatment efficacy in localized prostate cancer. J Urol. 1998;159:1606–1608
  12. Byar DP, Mostofi FK. Carcinoma of the prostate: prognostic evaluation of certain pathologic features in 208 radical prostatectomies (Examined by the step-section technique). Cancer. 1972;30(1):5–13
  13. Obek C, Louis P, Civantos F, et al. Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen. J Urol. 1999;161:494
  14. Salomon L, Colombel M, Patard JJ, et al. Value of ultrasound-guided systematic sextant biopsies in prostate tumor mapping. Eur Urol. 1999;35:289
  15. Hricak H, Williams RD, Spring DB, et al. Anatomy and pathology of the male pelvis by magnetic resonance imaging. AJR Am J Roentgenol. 1983;141:1101–1110
  16. Bezzi M, Kressel HY, Allen KS, et al. Prostatic carcinoma: staging with MR imaging at 1.5T. Radiology. 1988;168:339–346
  17. Hricak H, Choyke PL, Eberhardt SC, et al. Imaging prostate cancer: a multidisciplinary perspective. Radiology. 2007;243:28–53
  18. Rifkin MD, Zerhouni EA, Gatsonis CA, et al. Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer (Results of a multi-institutional cooperative trial). New Engl J Med. 1990;323:621–626
  19. Schnall MD, Pollack HM. Magnetic resonance imaging of the prostate gland. Urol Radiol. 1990;12:109–114
  20. Schiebler ML, Yankaskas BC, Tempany C, et al. MR imaging in adenocarcinoma of the prostate: interobserver variation and efficacy for determining stage C disease. AJR Am J Roentgenol. 1992;158:559–562
  21. Outwater EK, Petersen RO, Siegelman ES, et al. Prostate carcinoma: assessment of diagnostic criteria for capsular penetration on endorectal coil MR images. Radiology. 1994;193:333–339
  22. Bernstein MR, Cangiano T, D'Amico A, et al. Endorectal coil magnetic resonance imaging and clinicopathologic findings in T1c adenocarcinoma of the prostate. Urol Oncol. 2000;5:104–107
  23. May F, Treumann T, Dettmar P, et al. Limited value of endorectal magnetic resonance imaging and transrectal ultrasonography in the staging of clinically localized prostate cancer. BJU Int. 2001;87:66–69
  24. Cornud F, Flam T, Chauveinc L, et al. Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results. Radiology. 2002;224:203–210
  25. Mullerad M, Hricak H, Kuroiwa K, et al. Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. J Urol. 2005;174:2158–2163
  26. Yu KK, Hricak H, Alagappan R, et al. Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: multivariate feature analysis. Radiology. 1997;202:697–702
  27. Kurhanewicz J, Vigneron DB, Nelson SJ, et al. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. Urology. 1995;45:459–466
  28. Kurhanewicz J, Vigneron DB, Hricak H, et al. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high resolution (0.24-0.7-cm3) spatial resolution. Radiology. 1996;198:795–805
  29. Koh DM, Padhani AR. Diffusion-weighted MRI: a new functional clinical technique for tumour imaging. Br J Radiol. 2006;79:633–635
  30. Noworolski SM, Henry RG, Vigneron DB, et al. Dynamic contrast-enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI, and 3D MRSI. Magn Reson Med. 2005;53:249–255
  31. Scheidler J, Hricak H, Vigneron DB, et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging—clinicopathologic study. Radiology. 1999;213:473–480
  32. Denis LJ, Murphy GP, Schroeder FH. Report of the consensus workshop on screening and global strategy for prostate cancer. Cancer. 1995;75:1187–1207
  33. Coakley FV, Qayyum A, Kurhanewicz J. Magnetic resonance imaging and spectroscopic imaging of prostate cancer. J Urol. 2003;170:S69–S75
  34. Westphalen AC, Coakley FV, Qayyum A, et al. Peripheral zone prostate cancer: accuracy of different interpretive approaches with MR and MR spectroscopic imaging. Radiology. 2007;246:177–184
  35. Liney GP, Turnbull LW, Knowles AJ. In vivo magnetic resonance spectroscopy and dynamic contrast enhanced imaging of the prostate gland. NMR Biomed. 1999;12:39–44
  36. Kurhanewicz J, Swanson MG, Nelson SJ, et al. Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J Magn Reson Imaging. 2002;16:451–463
  37. Shukla-Dave A, Hricak H, Moskowitz C, et al. Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines. Radiology. 2007;245:499–506
  38. Males RG, Vigneron DB, Star-Lack J, et al. Clinical application of BASING and spectral/spatial water and lipid suppression pulses for prostate cancer staging and localization by in vivo 3D 1H magnetic resonance spectroscopic imaging. Magn Reson Med. 2000;43:17–22
  39. Zakian KL, Eberhardt S, Hricak H, et al. Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging–initial results. Radiology. 2003;229:241–247
  40. Wefer AE, Hricak H, Vigneron DB, et al. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol. 2000;164:400–404
  41. Hasumi M, Suzuki K, Taketomi A, et al. The combination of multivoxel MR spectroscopy with MR imaging improve the diagnostic accuracy for localization of prostate cancer. Anticancer Res. 2003;23:4223–4227
  42. Portalez D, Malavaud B, Herigault G, et al. Predicting prostate cancer with dynamic endorectal coil MR and proton spectroscopic MR imaging. J Radiol. 2004;85:1999–2004
  43. Squillaci E, Manenti G, Mancino S, et al. MR spectroscopy of prostate cancer (Initial clinical experience). J Exp Clin Cancer Res. 2005;24:523–530
  44. Vilanova JC, Barcelo J. Prostate cancer detection: MR spectroscopic imaging. Abdom Imaging. 2007;32:253–261
  45. Yu KK, Scheidler J, Hricak H, et al. Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology. 1999;213:481–488
  46. Wang L, Hricak H, Kattan MW, et al. Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms. Radiology. 2006;238:597–603
  47. Kurhanewicz J, Vigneron DB, Males RG, et al. The prostate: MR imaging and spectroscopy (Present and future). Radiol Clin North Am. 2000;38:115–138
  48. Zakian KL, Sircar K, Hricak H, et al. Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology. 2005;234:804–814
  49. Prando A, Billis A: Focal prostatic atrophy: mimicry of prostatic cancer on TRUS and 3D-MRSI studies. Abdom Imaging: printed online March 4, 2008
  50. Qayyum A, Coakley FV, Lu Y, et al. Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging. AJR Am J Roentgenol. 2004;183:1079–1083
  51. Kaji Y, Kurhanewicz J, Hricak H, et al. Localizing prostate cancer in the presence of post-biopsy change on MR images: role of proton MR spectroscopic imaging. Radiology. 1998;206:785–790
  52. Tien RD, Felsberg GJ, Friedman H, et al. MR imaging of high-grade cerebral gliomas: value of diffusion-weighted echoplanar pulse sequences. AJR Am J Roentgenol. 1994;162:671–677
  53. Sugahara T, Korogi Y, Kochi M, et al. Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging. 1999;9:53–60
  54. Castillo M, Smith JK, Kwock L, et al. Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. AJNR Am J Neuroradial. 2001;22:60–64
  55. Desouza NM, Reinsberg SA, Scurr ED, et al. Magnetic resonance imaging in prostate cancer: the value of apparent diffusion coefficients for identifying malignant nodules. Br J Radiol. 2007;80:90–95
  56. Gibbs P, Tozer DJ, Liney GP, et al. Comparison of quantitative T2 mapping and diffusion-weighted imaging in the normal and pathologic prostate. Magn Reson Med. 2001;46:1054–1058
  57. Bashar I. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging. J Magn Reson Imaging. 2002;16:196–200
  58. Hosseinzadeh K, Schwarz SD. Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue. J Magn Reson Imaging. 2004;20:654–661
  59. Kozlowski P, Chang SD, Jones EC, et al. Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis—correlation with biopsy and histopathology. J Magn Reson Imaging. 2006;24:108–113
  60. Kozlowski P, Chang SD, Goldenberg SL. Diffusion-weighted MRI in prostate cancer—comparison between single-shot fast spin echo and echo planar imaging sequences. Magn Reson Imaging. 2008;26:72–76
  61. Ichikawa T, Haradome H, Hachiya J, et al. Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions. AJR Am J Roentgenol. 1998;170:397–402
  62. Ichikawa T, Haradome H, Hachiya J, et al. Diffusion-weighted MR imaging with single-shot echo-planar imaging in the upper abdomen: preliminary clinical experience in 61 patients. Abdom Imaging. 1999;24:456–461
  63. Haider MA, Kwast TH, Tanguay J, et al. Combined T2-weighted and diffusion weighted MRI for Localization of prostate cancer. AJR Am J Roentgenol. 2007;189:323–328
  64. DeSouza N, Riches S, vanAs N, et al. Potential value of diffusion weighted imaging as an indicator of tumor aggressiveness in prostate cancer. In: Proceedings of the International Society of Magnetic Resonance in Medicine 15, May 19-25. Berlin. 2007;p. 3659
  65. DeSouza NM, Gilderdale DJ, Puni R, et al. A solid reusable endorectal receiver coil for magnetic resonance imaging of the prostate: design, use, and comparison with an inflatable endorectal coil. J Magn Reson Imaging. 1996;6:801–804
  66. Rosen Y, Bloch BN, Lenkinski RE, et al. 3T MR of the prostate: reducing susceptibility gradients by inflating the endorectal coil with a barium sulfate suspension. Magn Reson Med. 2007;57:898–904
  67. Brown G, Macvicar DA, Ayton V, et al. The role of intravenous contrast enhancement in magnetic resonance imaging of prostatic carcinoma. Clin Radiol. 1995;50:601–606
  68. Liney GP, Turnbull LW, Knowles AJ. In vivo magnetic resonance spectroscopy and dynamic contrast enhanced imaging of the prostate gland. NMR Biomed. 1999;12:39–44
  69. Jager GJ, Ruijter ET, van de Kaa CA, et al. Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. Radiology. 1997;203:645–652
  70. Jager GJ, Ruijter ET, van de Kaa CA, et al. Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. AJR Am J Roentgenol. 1996;166:845–852
  71. Barentsz JO, Engelbrecht M, Jager GJ, et al. Fast dynamic gadolinium-enhanced MR imaging of urinary bladder and prostate cancer. J Magn Reson Imaging. 1999;10:295–304
  72. Namimoto T, Morishita S, Saitoh R, et al. The value of dynamic MR imaging for hypointensity lesions of the peripheral zone of the prostate. Comput Med Imaging Graph. 1998;22:239–245
  73. Padhani AR, Gapinski CJ, Macvicar DA, et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol. 2000;55:99–109
  74. Padhani AR, Hayes C, Landau S, et al. Reproducibility of quantitative dynamic MRI of normal human tissues. NMR Biomed. 2002;15:143–153
  75. Engelbrecht MR, Huisman HJ, Laheij RJ, et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology. 2003;229:248–254
  76. Buckley DL, Roberts C, Parker GJ, et al. Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging—initial experience. Radiology. 2004;233:709–715
  77. Alonzi R, Padhani AR, Allen C. Dynamic contrast enhanced MRI in prostate cancer. Eur J Radiol. 2007;63:335–350
  78. Kurhanewicz J, Vigneron D, Carroll P, et al. Multiparametric magnetic resonance imaging in prostate cancer: present and future. Curr Opin Urol. 2008;18:71–77
  79. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging. 1999;10:223–232
  80. Tofts PS. Modeling tracer kinetics in dynamic Gd-D TPA MR imaging. J Magn Reson Imaging. 1997;7:91–101
  81. Hara N, Okuizumi M, Koike H, et al. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer. Prostate. 2005;62:140–147
  82. Fütterer JJ, Engelbrecht MR, Huisman HJ, et al. Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers. Radiology. 2005;237:541–549
  83. Reinsberg SA, Payne GS, Riches SF, et al. Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection. AJR Am J Roentgenol. 2007;188:91–98
  84. Van Dorsten FA, Van der Graaf M, Engelbrecht MR, et al. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer. J Magn Reson Imaging. 2004;20:279–287
  85. Noworolski SM, Henry RG, Vigneron DB, et al. Dynamic contrast-enhanced MRI in normal and abnormal prostate tissue as defined by biopsy, MRI, and MRSI. Magn Reson Med. 2005;53:249–255
  86. Futterer JJ, Heijmink SW, Scheenen TW, et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology. 2006;241:449–458
  87. Cornfeld DM, Weinreb JC. MR imaging of the prostate: 1.5T versus 3T. Magn Reson Imaging Clin North Am. 2007;15:433–448
  88. Heijmink SW, Fütterer JJ, Hambrock T, et al. Prostate cancer: body-array versus endorectal coil MR imaging at 3 T—comparison of image quality, localization, and staging performance. Radiology. 2007;244:184–195
  89. Fütterer JJ, Scheenen TW, Huisman HJ, et al. Initial experience of 3 tesla endorectal coil magnetic resonance imaging and 1H-spectroscopic imaging of the prostate. Invest Radiol. 2004;39:671–680
  90. Pickles M, Gibbs P, Sreenivas M, et al. Diffusion-weighted imaging of normal and malignant prostate tissue at 3T. J Magn Reson Imaging. 2006;23:130–134
  91. Chen A, Xu D, Sotto C, et al. High resolution MRSI and DTI of prostate cancer at 3T. In: Proceedings of the International Society of Magnetic Resonance in Medicine 15, May 19-25. Berlin. 2007;p. 2887
  92. Hamilton G, Middelton M, Choi S, et al. Improved MR spectral analysis for a PFC-filled endo-rectal prostate surface coil compared to an air-filled coil. In: Proceedings of the International Society of Magnetic Resonance in Medicine 15, May 19-25. Berlin. 2007;p. 1400
  93. Scheenen TW, Heijmink SW, Roell SA, et al. Three-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: feasibility. Radiology. 2007;245:507–516
  94. Gibbs P, Pickles MD, Turnbull LW. Diffusion imaging of the prostate at 3.0 Tesla. Invest Radiol. 2006;41:185–188
  95. Fuchsjäger M, Shukla-Dave A, Akin O, et al. Prostate cancer imaging. Acta Radiol. 2008;49:107–120

PII: S0037-198X(08)00044-8

doi: 10.1053/j.ro.2008.06.002

Seminars in Roentgenology
Volume 43, Issue 4 , Pages 303-313 , October 2008

Article Tools

* Image Usage & Resolution